METTLER TOLEDO INTERNATIONAL INC/ MTD
We are a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key research and development, quality control, and manufacturing processes for customers in a wide range of industries including life sciences, food, and chemicals. Our sales and service network is one of the most extensive in the industry. Our products are sold in more than 140 countries and we have a direct presence in approximately 40 countries. With proven growth strategies and a focus on execution, we have achieved a long-term track record of strong financial performance.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.03B | $3.87B | $3.79B | $3.92B | $3.72B | $3.09B | $3.01B | $2.94B | $2.73B | $2.51B |
| Cost of revenue | — | — | — | — | — | — | — | — | $317.9M | $304.9M |
| Gross profit | $2.39B | $2.33B | $2.24B | $2.31B | $2.17B | $1.80B | $1.74B | $1.68B | $1.58B | $1.44B |
| R&D | $199.4M | $189.4M | $185.3M | $177.1M | $169.8M | $140.1M | $143.9M | $141.1M | $128.3M | $119.2M |
| SG&A | $998.3M | $936.3M | $904.1M | $938.5M | $944.0M | $820.2M | $819.2M | $812.8M | $794.9M | $745.4M |
| Interest expense | $68.5M | $74.6M | $77.4M | $55.4M | $43.2M | $38.6M | $37.4M | $34.5M | $32.8M | $28.0M |
| Pre-tax income | $1.05B | $1.04B | $973.7M | $1.07B | $949.4M | $748.7M | $681.4M | $651.9M | $574.2M | $504.2M |
| Income tax | $179.7M | $174.1M | $184.9M | $198.1M | $180.4M | $146.0M | $120.3M | $139.2M | $198.2M | $119.8M |
| Net income | $869.2M | $863.1M | $788.8M | $872.5M | $769.0M | $602.7M | $561.1M | $512.6M | $376.0M | $384.4M |
| EPS, basic | 42.17 | 40.67 | 36.10 | 38.79 | 33.25 | 25.24 | 22.84 | 20.33 | 14.62 | 14.49 |
| EPS, diluted | 42.05 | 40.48 | 35.90 | 38.41 | 32.78 | 24.91 | 22.47 | 19.88 | 14.24 | 14.22 |
| Shares, diluted (wtd. avg.) | $20.7M | $21.3M | $22.0M | $22.7M | $23.5M | $24.2M | $25.0M | $25.8M | $26.4M | $27.0M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $66.9M | $59.4M | $69.8M | $96.0M | $98.6M | $94.3M | $207.8M | $178.1M | $148.7M | $158.7M |
| Receivables | $778.2M | $687.1M | $663.9M | $709.3M | $647.3M | $593.8M | $566.3M | $535.5M | — | — |
| Inventory | $387.2M | $342.3M | $385.9M | $441.7M | $414.5M | $297.6M | $274.3M | $268.8M | — | — |
| Total current assets | $1.36B | $1.19B | $1.23B | $1.38B | $1.27B | $1.06B | $1.11B | $1.05B | — | — |
| Property, plant and equipment | $845.6M | $770.3M | $803.4M | $778.6M | $799.4M | $798.9M | $748.7M | $717.5M | — | — |
| Goodwill | $739.2M | $668.9M | $670.1M | $660.2M | $648.6M | $550.3M | $536.0M | $534.8M | $539.8M | — |
| Other intangibles | $278.9M | $257.1M | $285.4M | $306.1M | $307.4M | $196.8M | $206.2M | $217.3M | — | — |
| Total assets | $3.71B | $3.24B | $3.36B | $3.49B | $3.33B | $2.81B | $2.79B | $2.62B | $2.55B | — |
| Accounts payable | $266.6M | $215.8M | $210.4M | $252.5M | $272.9M | $175.8M | $185.6M | $196.6M | — | — |
| Short-term debt | $63.9M | $182.6M | $192.2M | $106.1M | $101.1M | $50.3M | $55.9M | $49.7M | — | — |
| Total current liabilities | $1.20B | $1.17B | $1.18B | $1.15B | $1.15B | $840.3M | $754.5M | $734.4M | — | — |
| Long-term debt | $2.09B | $1.83B | $1.89B | $1.91B | $1.58B | $1.28B | $1.24B | $985.0M | — | — |
| Total liabilities | $3.74B | $3.37B | $3.51B | $3.47B | $3.16B | $2.53B | $2.37B | $2.03B | — | — |
| Retained earnings | $9.24B | $8.37B | $7.51B | $6.73B | $5.86B | $5.10B | $4.50B | $3.94B | — | — |
| Total equity | -$23.6M | -$126.9M | -$149.9M | $24.8M | $171.4M | $282.7M | $420.8M | $590.1M | $547.3M | $434.9M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $955.8M | $968.3M | $965.9M | $859.1M | $908.8M | $724.7M | $603.5M | $565.0M | $516.3M | $460.8M |
| Depreciation and amortisation | $51.1M | $50.4M | $49.0M | $46.8M | $45.0M | $42.0M | $39.0M | $37.2M | $33.5M | $32.7M |
| Stock-based compensation | $22.5M | $20.0M | $17.9M | $19.7M | $19.6M | $18.7M | $18.3M | $17.6M | $16.6M | $15.3M |
| Capital expenditure | $107.1M | $103.9M | $105.3M | $121.2M | $107.6M | $92.5M | $97.3M | $142.7M | $127.4M | $124.0M |
| Investing cash flow | -$193.9M | -$119.5M | -$131.7M | -$139.4M | -$314.1M | -$100.4M | -$99.1M | -$138.9M | -$217.3M | -$231.5M |
| Financing cash flow | -$755.2M | -$856.0M | -$859.6M | -$716.0M | -$590.5M | -$743.9M | -$477.4M | -$388.0M | -$319.5M | -$163.6M |
| Buybacks | $800.0M | $850.0M | $900.0M | $1.10B | $1,000.0M | $775.0M | $775.0M | $475.0M | $400.0M | $500.0M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001037646-26-000011.
Others in SIC 3826
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| A | AGILENT TECHNOLOGIES, INC. | $42.53B | 33.0x | 6.7% |
| WAT | WATERS CORP /DE/ | $40.22B | 38.0x | 7.0% |
| ILMN | ILLUMINA, INC. | $32.95B | 40.0x | -0.7% |
| RVTY | REVVITY, INC. | $14.53B | 62.9x | 3.7% |
| BIO | BIO-RAD LABORATORIES, INC. | $10.33B | 13.9x | 0.7% |
| AVTR | Avantor, Inc. | $10.22B | — | -3.4% |
| BRKR | BRUKER CORP | $8.88B | — | 2.1% |
| TXG | 10x Genomics, Inc. | $8.14B | — | 5.2% |